| | | | |
CUSIP NO. 50107A104 | | 13 G | | Page 7 of 11 Pages |
Introductory Note: This statement on Schedule 13G is filed on behalf of the Reporting Persons, in respect of shares of Common Stock (“Common Stock”), of Kronos Bio, Inc. (the “Issuer”).
Kronos Bio, Inc. (the “Issuer”)
Item 1(b) | Address of Issuer’s principal executive offices: |
Kronos Bio, Inc.
1300 So. El Camino Real, Suite 300
San Mateo, CA 94402
Items | 2(a) Name of Reporting Persons filing: |
Omega Fund V, L.P. (“Omega Fund”)
Omega Fund V GP, L.P. (“Omega GP”)
Omega Fund V GP Manager, Ltd. (“Omega Ltd”)
Claudio Nessi (“Nessi”)
Otello Stampacchia (“Stampacchia”)
Item 2(b) | Address or principal business office or, if none, residence: |
The address of the principal business office of Omega Fund, Omega GP, Omega Ltd, Nessi and Stampacchia, is c/o Omega Fund Management, LLC, 888 Boylston Street, Suite 1111, Boston, MA 02199.
| | |
Name | | Citizenship or Place of Organization |
Omega Fund | | Cayman Islands |
Omega GP | | Cayman Islands |
Omega Ltd | | Cayman Islands |
Nessi | | Switzerland |
Stampacchia | | Italy |
Item 2(d) | Title of class of securities: |
Common Stock
50107A104
Item 3 | If this statement is filed pursuant to §§ 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filings is a: |
Not applicable.